ARK Israel Innovative Tec... (IZRL)
CBOE: IZRL
· Real-Time Price · USD
27.20
0.01 (0.04%)
At close: Aug 18, 2025, 2:59 PM
0.04% (1D)
Bid | 26 |
Market Cap | 118.35M |
AUM | 116.4M |
NAV | 27.31 |
EPS (ttm) | 1.12 |
PE Ratio (ttm) | 24.22 |
Shares Out | 4.35M |
Inception Date | Dec 5, 2017 |
Ask | 27.39 |
Volume | 15.35K |
Open | 27.09 |
Previous Close | 27.19 |
Day's Range | 26.84 - 27.20 |
52-Week Range | 18.20 - 28.95 |
Holdings | 76 |
Expense Ratio | 0.49% |
About IZRL
The ARK Israel Innovative Technology ETF (IZRL) seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the ARK Israeli Innovation Index, which is designed to track the price movements of exchange-listed Israeli companies whose main business operations are causing disruptive innovation in the areas of genomics, health care, biotechnology, industrials, manufacturing, the Internet or information technology.
Asset Class Equity
Ticker Symbol IZRL
Inception Date Dec 5, 2017
Provider ARK
Website Fund Home Page
Exchange CBOE
Top Sectors
Sector | Weight % |
---|---|
Technology | 55.33% |
Communication Services | 14.80% |
Healthcare | 12.13% |
Industrials | 9.31% |
Consumer Cyclical | 6.61% |
Top 10 Holdings 19.85% of assets
Name | Symbol | Weight |
---|---|---|
Tat Technologies Ltd | TATTF | 2.14% |
Urogen Pharma Ltd. | URGN | 2.12% |
Aryt Industries Ltd | ARYT | 2.11% |
Gilat Satellite Netw... | GILT | 2.03% |
Rp Optical Lab Ltd | RPOL | 2.00% |
Bet Shemesh Engines ... | BSEN | 1.96% |
Ituran Location And ... | ITRN | 1.90% |
Elbit Systems Ltd. | ESLT | 1.88% |
Cyberark Software Lt... | CYBR | 1.87% |
Walkme Ltd. | WKME | 1.84% |
Dividends Dividend Yield 0.46%
Ex-Dividend | Amount | Payment Date |
---|---|---|
Dec 27, 2024 | $0.1012 | Dec 30, 2024 |
Dec 29, 2021 | $0.0956 | Dec 31, 2021 |
Dec 27, 2019 | $0.4753 | Dec 31, 2019 |
Dec 27, 2018 | $0.5721 | Dec 31, 2018 |

3 months ago · seekingalpha.com
IZRL: This Innovation-Focused ETF Lags Broader Israeli Stock MarketIZRL aims to capture returns from Israeli companies driving disruptive innovation across multiple sectors, but its strategy has underperformed since inception. The fund's investment thesis overstates ...